Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Secreted. |
Domain |
PF00019 Transforming growth factor beta like domain PF00688 TGF-beta propeptide |
Function |
TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth. |
Biological Process |
GO:0001501 skeletal system development GO:0001502 cartilage condensation GO:0001503 ossification GO:0001525 angiogenesis GO:0001558 regulation of cell growth GO:0001654 eye development GO:0001655 urogenital system development GO:0001666 response to hypoxia GO:0001667 ameboidal-type cell migration GO:0001776 leukocyte homeostasis GO:0001818 negative regulation of cytokine production GO:0001822 kidney development GO:0001837 epithelial to mesenchymal transition GO:0001838 embryonic epithelial tube formation GO:0001841 neural tube formation GO:0001843 neural tube closure GO:0001942 hair follicle development GO:0001974 blood vessel remodeling GO:0002260 lymphocyte homeostasis GO:0002367 cytokine production involved in immune response GO:0002440 production of molecular mediator of immune response GO:0002576 platelet degranulation GO:0002683 negative regulation of immune system process GO:0002697 regulation of immune effector process GO:0002698 negative regulation of immune effector process GO:0002700 regulation of production of molecular mediator of immune response GO:0002701 negative regulation of production of molecular mediator of immune response GO:0002718 regulation of cytokine production involved in immune response GO:0002719 negative regulation of cytokine production involved in immune response GO:0003007 heart morphogenesis GO:0003013 circulatory system process GO:0003015 heart process GO:0003148 outflow tract septum morphogenesis GO:0003149 membranous septum morphogenesis GO:0003151 outflow tract morphogenesis GO:0003170 heart valve development GO:0003171 atrioventricular valve development GO:0003177 pulmonary valve development GO:0003179 heart valve morphogenesis GO:0003181 atrioventricular valve morphogenesis GO:0003184 pulmonary valve morphogenesis GO:0003197 endocardial cushion development GO:0003198 epithelial to mesenchymal transition involved in endocardial cushion formation GO:0003203 endocardial cushion morphogenesis GO:0003205 cardiac chamber development GO:0003206 cardiac chamber morphogenesis GO:0003208 cardiac ventricle morphogenesis GO:0003209 cardiac atrium morphogenesis GO:0003215 cardiac right ventricle morphogenesis GO:0003222 ventricular trabecula myocardium morphogenesis GO:0003229 ventricular cardiac muscle tissue development GO:0003230 cardiac atrium development GO:0003231 cardiac ventricle development GO:0003272 endocardial cushion formation GO:0003274 endocardial cushion fusion GO:0003275 apoptotic process involved in outflow tract morphogenesis GO:0003278 apoptotic process involved in heart morphogenesis GO:0003279 cardiac septum development GO:0003281 ventricular septum development GO:0003283 atrial septum development GO:0003284 septum primum development GO:0003289 atrial septum primum morphogenesis GO:0003407 neural retina development GO:0006584 catecholamine metabolic process GO:0006606 protein import into nucleus GO:0006887 exocytosis GO:0006913 nucleocytoplasmic transport GO:0006924 activation-induced cell death of T cells GO:0007009 plasma membrane organization GO:0007050 cell cycle arrest GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007179 transforming growth factor beta receptor signaling pathway GO:0007184 SMAD protein import into nucleus GO:0007265 Ras protein signal transduction GO:0007409 axonogenesis GO:0007411 axon guidance GO:0007423 sensory organ development GO:0007431 salivary gland development GO:0007435 salivary gland morphogenesis GO:0007507 heart development GO:0007517 muscle organ development GO:0007548 sex differentiation GO:0008015 blood circulation GO:0008016 regulation of heart contraction GO:0008347 glial cell migration GO:0008406 gonad development GO:0008544 epidermis development GO:0008584 male gonad development GO:0009306 protein secretion GO:0009712 catechol-containing compound metabolic process GO:0009713 catechol-containing compound biosynthetic process GO:0010002 cardioblast differentiation GO:0010171 body morphogenesis GO:0010631 epithelial cell migration GO:0010632 regulation of epithelial cell migration GO:0010634 positive regulation of epithelial cell migration GO:0010692 regulation of alkaline phosphatase activity GO:0010693 negative regulation of alkaline phosphatase activity GO:0010715 regulation of extracellular matrix disassembly GO:0010717 regulation of epithelial to mesenchymal transition GO:0010718 positive regulation of epithelial to mesenchymal transition GO:0010719 negative regulation of epithelial to mesenchymal transition GO:0010862 positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010921 regulation of phosphatase activity GO:0010923 negative regulation of phosphatase activity GO:0010934 macrophage cytokine production GO:0010935 regulation of macrophage cytokine production GO:0010936 negative regulation of macrophage cytokine production GO:0014020 primary neural tube formation GO:0014065 phosphatidylinositol 3-kinase signaling GO:0014066 regulation of phosphatidylinositol 3-kinase signaling GO:0014068 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014706 striated muscle tissue development GO:0014855 striated muscle cell proliferation GO:0016049 cell growth GO:0016311 dephosphorylation GO:0016331 morphogenesis of embryonic epithelium GO:0017038 protein import GO:0017145 stem cell division GO:0018958 phenol-containing compound metabolic process GO:0021700 developmental maturation GO:0021915 neural tube development GO:0022404 molting cycle process GO:0022405 hair cycle process GO:0022602 ovulation cycle process GO:0022612 gland morphogenesis GO:0022617 extracellular matrix disassembly GO:0030198 extracellular matrix organization GO:0030199 collagen fibril organization GO:0030278 regulation of ossification GO:0030307 positive regulation of cell growth GO:0030308 negative regulation of cell growth GO:0030326 embryonic limb morphogenesis GO:0030335 positive regulation of cell migration GO:0030593 neutrophil chemotaxis GO:0030595 leukocyte chemotaxis GO:0031069 hair follicle morphogenesis GO:0031098 stress-activated protein kinase signaling cascade GO:0032147 activation of protein kinase activity GO:0032570 response to progesterone GO:0032844 regulation of homeostatic process GO:0032846 positive regulation of homeostatic process GO:0032872 regulation of stress-activated MAPK cascade GO:0032874 positive regulation of stress-activated MAPK cascade GO:0032906 transforming growth factor beta2 production GO:0032909 regulation of transforming growth factor beta2 production GO:0032956 regulation of actin cytoskeleton organization GO:0032970 regulation of actin filament-based process GO:0033002 muscle cell proliferation GO:0033627 cell adhesion mediated by integrin GO:0033628 regulation of cell adhesion mediated by integrin GO:0033630 positive regulation of cell adhesion mediated by integrin GO:0033674 positive regulation of kinase activity GO:0034330 cell junction organization GO:0034504 protein localization to nucleus GO:0035051 cardiocyte differentiation GO:0035107 appendage morphogenesis GO:0035108 limb morphogenesis GO:0035113 embryonic appendage morphogenesis GO:0035148 tube formation GO:0035239 tube morphogenesis GO:0035265 organ growth GO:0035272 exocrine system development GO:0035303 regulation of dephosphorylation GO:0035305 negative regulation of dephosphorylation GO:0035904 aorta development GO:0035905 ascending aorta development GO:0035909 aorta morphogenesis GO:0035910 ascending aorta morphogenesis GO:0036293 response to decreased oxygen levels GO:0038034 signal transduction in absence of ligand GO:0040017 positive regulation of locomotion GO:0042063 gliogenesis GO:0042303 molting cycle GO:0042416 dopamine biosynthetic process GO:0042417 dopamine metabolic process GO:0042423 catecholamine biosynthetic process GO:0042476 odontogenesis GO:0042493 response to drug GO:0042633 hair cycle GO:0042634 regulation of hair cycle GO:0042635 positive regulation of hair cycle GO:0042637 catagen GO:0042698 ovulation cycle GO:0042704 uterine wall breakdown GO:0043010 camera-type eye development GO:0043029 T cell homeostasis GO:0043062 extracellular structure organization GO:0043410 positive regulation of MAPK cascade GO:0043523 regulation of neuron apoptotic process GO:0043525 positive regulation of neuron apoptotic process GO:0043583 ear development GO:0043588 skin development GO:0044057 regulation of system process GO:0044744 protein targeting to nucleus GO:0044848 biological phase GO:0044851 hair cycle phase GO:0045055 regulated exocytosis GO:0045112 integrin biosynthetic process GO:0045113 regulation of integrin biosynthetic process GO:0045137 development of primary sexual characteristics GO:0045165 cell fate commitment GO:0045216 cell-cell junction organization GO:0045682 regulation of epidermis development GO:0045684 positive regulation of epidermis development GO:0045726 positive regulation of integrin biosynthetic process GO:0045778 positive regulation of ossification GO:0045785 positive regulation of cell adhesion GO:0045786 negative regulation of cell cycle GO:0045787 positive regulation of cell cycle GO:0045823 positive regulation of heart contraction GO:0045860 positive regulation of protein kinase activity GO:0045926 negative regulation of growth GO:0045927 positive regulation of growth GO:0046189 phenol-containing compound biosynthetic process GO:0046546 development of primary male sexual characteristics GO:0046578 regulation of Ras protein signal transduction GO:0046580 negative regulation of Ras protein signal transduction GO:0046661 male sex differentiation GO:0048015 phosphatidylinositol-mediated signaling GO:0048017 inositol lipid-mediated signaling GO:0048103 somatic stem cell division GO:0048511 rhythmic process GO:0048514 blood vessel morphogenesis GO:0048545 response to steroid hormone GO:0048565 digestive tract development GO:0048566 embryonic digestive tract development GO:0048568 embryonic organ development GO:0048608 reproductive structure development GO:0048644 muscle organ morphogenesis GO:0048663 neuron fate commitment GO:0048667 cell morphogenesis involved in neuron differentiation GO:0048705 skeletal system morphogenesis GO:0048730 epidermis morphogenesis GO:0048732 gland development GO:0048736 appendage development GO:0048738 cardiac muscle tissue development GO:0048762 mesenchymal cell differentiation GO:0048771 tissue remodeling GO:0048818 positive regulation of hair follicle maturation GO:0048819 regulation of hair follicle maturation GO:0048820 hair follicle maturation GO:0048839 inner ear development GO:0048844 artery morphogenesis GO:0048863 stem cell differentiation GO:0048872 homeostasis of number of cells GO:0050673 epithelial cell proliferation GO:0050678 regulation of epithelial cell proliferation GO:0050680 negative regulation of epithelial cell proliferation GO:0050708 regulation of protein secretion GO:0050714 positive regulation of protein secretion GO:0050777 negative regulation of immune response GO:0050900 leukocyte migration GO:0051047 positive regulation of secretion GO:0051056 regulation of small GTPase mediated signal transduction GO:0051058 negative regulation of small GTPase mediated signal transduction GO:0051098 regulation of binding GO:0051099 positive regulation of binding GO:0051169 nuclear transport GO:0051170 nuclear import GO:0051216 cartilage development GO:0051222 positive regulation of protein transport GO:0051272 positive regulation of cellular component movement GO:0051302 regulation of cell division GO:0051346 negative regulation of hydrolase activity GO:0051402 neuron apoptotic process GO:0051403 stress-activated MAPK cascade GO:0051493 regulation of cytoskeleton organization GO:0051781 positive regulation of cell division GO:0051794 regulation of catagen GO:0051795 positive regulation of catagen GO:0051797 regulation of hair follicle development GO:0051798 positive regulation of hair follicle development GO:0051890 regulation of cardioblast differentiation GO:0051891 positive regulation of cardioblast differentiation GO:0055008 cardiac muscle tissue morphogenesis GO:0055010 ventricular cardiac muscle tissue morphogenesis GO:0055017 cardiac muscle tissue growth GO:0055123 digestive system development GO:0060021 palate development GO:0060037 pharyngeal system development GO:0060038 cardiac muscle cell proliferation GO:0060041 retina development in camera-type eye GO:0060047 heart contraction GO:0060065 uterus development GO:0060173 limb development GO:0060317 cardiac epithelial to mesenchymal transition GO:0060323 head morphogenesis GO:0060324 face development GO:0060325 face morphogenesis GO:0060326 cell chemotaxis GO:0060389 pathway-restricted SMAD protein phosphorylation GO:0060393 regulation of pathway-restricted SMAD protein phosphorylation GO:0060395 SMAD protein signal transduction GO:0060411 cardiac septum morphogenesis GO:0060412 ventricular septum morphogenesis GO:0060413 atrial septum morphogenesis GO:0060415 muscle tissue morphogenesis GO:0060419 heart growth GO:0060485 mesenchyme development GO:0060537 muscle tissue development GO:0060561 apoptotic process involved in morphogenesis GO:0060562 epithelial tube morphogenesis GO:0060606 tube closure GO:0060840 artery development GO:0061035 regulation of cartilage development GO:0061037 negative regulation of cartilage development GO:0061082 myeloid leukocyte cytokine production GO:0061343 cell adhesion involved in heart morphogenesis GO:0061383 trabecula morphogenesis GO:0061384 heart trabecula morphogenesis GO:0061448 connective tissue development GO:0061458 reproductive system development GO:0061564 axon development GO:0061626 pharyngeal arch artery morphogenesis GO:0070227 lymphocyte apoptotic process GO:0070228 regulation of lymphocyte apoptotic process GO:0070230 positive regulation of lymphocyte apoptotic process GO:0070231 T cell apoptotic process GO:0070232 regulation of T cell apoptotic process GO:0070234 positive regulation of T cell apoptotic process GO:0070235 regulation of activation-induced cell death of T cells GO:0070237 positive regulation of activation-induced cell death of T cells GO:0070302 regulation of stress-activated protein kinase signaling cascade GO:0070304 positive regulation of stress-activated protein kinase signaling cascade GO:0070482 response to oxygen levels GO:0070997 neuron death GO:0071559 response to transforming growth factor beta GO:0071560 cellular response to transforming growth factor beta stimulus GO:0071604 transforming growth factor beta production GO:0071621 granulocyte chemotaxis GO:0071634 regulation of transforming growth factor beta production GO:0071695 anatomical structure maturation GO:0071887 leukocyte apoptotic process GO:0072001 renal system development GO:0072132 mesenchyme morphogenesis GO:0072175 epithelial tube formation GO:0090091 positive regulation of extracellular matrix disassembly GO:0090092 regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090100 positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090130 tissue migration GO:0090132 epithelium migration GO:0097191 extrinsic apoptotic signaling pathway GO:0097192 extrinsic apoptotic signaling pathway in absence of ligand GO:0097485 neuron projection guidance GO:0097529 myeloid leukocyte migration GO:0097530 granulocyte migration GO:0098742 cell-cell adhesion via plasma-membrane adhesion molecules GO:0098743 cell aggregation GO:0098773 skin epidermis development GO:1900180 regulation of protein localization to nucleus GO:1900182 positive regulation of protein localization to nucleus GO:1901214 regulation of neuron death GO:1901216 positive regulation of neuron death GO:1901615 organic hydroxy compound metabolic process GO:1901617 organic hydroxy compound biosynthetic process GO:1901654 response to ketone GO:1902256 regulation of apoptotic process involved in outflow tract morphogenesis GO:1902337 regulation of apoptotic process involved in morphogenesis GO:1902532 negative regulation of intracellular signal transduction GO:1902593 single-organism nuclear import GO:1902742 apoptotic process involved in development GO:1903053 regulation of extracellular matrix organization GO:1903055 positive regulation of extracellular matrix organization GO:1903522 regulation of blood circulation GO:1903524 positive regulation of blood circulation GO:1903532 positive regulation of secretion by cell GO:1903701 substantia propria of cornea development GO:1903729 regulation of plasma membrane organization GO:1903829 positive regulation of cellular protein localization GO:1904424 regulation of GTP binding GO:1904426 positive regulation of GTP binding GO:1904748 regulation of apoptotic process involved in development GO:1904888 cranial skeletal system development GO:1904951 positive regulation of establishment of protein localization GO:1905005 regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905006 negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905007 positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905207 regulation of cardiocyte differentiation GO:1905209 positive regulation of cardiocyte differentiation GO:1905314 semi-lunar valve development GO:1990266 neutrophil migration GO:2000027 regulation of organ morphogenesis GO:2000106 regulation of leukocyte apoptotic process GO:2000108 positive regulation of leukocyte apoptotic process GO:2000147 positive regulation of cell motility GO:2000736 regulation of stem cell differentiation GO:2000738 positive regulation of stem cell differentiation GO:2000826 regulation of heart morphogenesis GO:2001233 regulation of apoptotic signaling pathway GO:2001235 positive regulation of apoptotic signaling pathway GO:2001236 regulation of extrinsic apoptotic signaling pathway GO:2001238 positive regulation of extrinsic apoptotic signaling pathway GO:2001239 regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001241 positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
Molecular Function |
GO:0001540 beta-amyloid binding GO:0004674 protein serine/threonine kinase activity GO:0004702 receptor signaling protein serine/threonine kinase activity GO:0005057 receptor signaling protein activity GO:0005114 type II transforming growth factor beta receptor binding GO:0005125 cytokine activity GO:0005126 cytokine receptor binding GO:0005160 transforming growth factor beta receptor binding GO:0008083 growth factor activity GO:0033218 amide binding GO:0034714 type III transforming growth factor beta receptor binding GO:0042277 peptide binding GO:0046982 protein heterodimerization activity |
Cellular Component |
GO:0030141 secretory granule GO:0030424 axon GO:0031091 platelet alpha granule GO:0031093 platelet alpha granule lumen GO:0031983 vesicle lumen GO:0034774 secretory granule lumen GO:0043025 neuronal cell body GO:0044297 cell body GO:0060205 cytoplasmic membrane-bounded vesicle lumen GO:0099503 secretory vesicle |
KEGG |
hsa04010 MAPK signaling pathway hsa04060 Cytokine-cytokine receptor interaction hsa04068 FoxO signaling pathway hsa04110 Cell cycle hsa04144 Endocytosis hsa04350 TGF-beta signaling pathway hsa04380 Osteoclast differentiation hsa04390 Hippo signaling pathway |
Reactome |
R-HSA-3000178: ECM proteoglycans R-HSA-1566948: Elastic fibre formation R-HSA-1474244: Extracellular matrix organization R-HSA-109582: Hemostasis R-HSA-2129379: Molecules associated with elastic fibres R-HSA-76002: Platelet activation, signaling and aggregation R-HSA-114608: Platelet degranulation R-HSA-76005: Response to elevated platelet cytosolic Ca2+ |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between TGFB2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between TGFB2 and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of TGFB2 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of TGFB2 in various data sets.
|
Points in the above scatter plot represent the mutation difference of TGFB2 in various data sets.
|
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of TGFB2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of TGFB2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by TGFB2. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of TGFB2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of TGFB2 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between TGFB2 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | TGFB2 |
Name | transforming growth factor, beta 2 |
Aliases | prepro-transforming growth factor beta-2; LDS4; TGF-beta2; BSC-1 cell growth inhibitor; G-TSF; cetermin; gli ...... |
Chromosomal Location | 1q41 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting TGFB2 collected from DrugBank database. |
There is no record. |